Lisa Dumkow
@LisaIDpharmD
Followers
1K
Following
5K
Media
161
Statuses
578
Stewardship pharmacist who loves bugs and drugs, dog hugs, and running!
Grand Rapids, MI
Joined May 2014
GN-BSI Stewardship 🆕💫🦠 ICHE 2025: In a 22-hospital system (3,231 patients), GN-BSI care became shorter, safer, and more oral. 🚀 What changed 1️⃣ OPAT review for all planned IV discharges 2️⃣ GN-BSI guideline → oral step-down + 7-day therapy criteria 🔥 Key wins 💉 IV at
cambridge.org
Interventions to optimize duration of antibiotic therapy and encourage oral transition for uncomplicated gram-negative blood stream infections across a health system
0
24
69
🤩 Honored to speak at the IDWeek 2025, in Atlanta, Georgia 🇺🇸 In case you missed the session on Expanding Global Stewardship Through Cultural Humility and Community Engagement, access IDWeek on demand for registered delegates at https://t.co/RybSNyJK53
2
2
2
🔔 Register & catch the first webinar tomorrow, co-moderated by @SIDPharm member and InterOrg Vice Chair @kristadgens! #IDSky #AMR
💊Be sure to join the first webinar of our 4-part series leading up to World AMR Awareness Week 2025. This opening event next Tues, 28 Oct will explore #AMR in conflict and crisis zones diving into the geopolitical facet of combating AMR. Register today: https://t.co/sv1di7cbpk
0
0
6
🆕💫 Retrospective, multicenter cohort study(N: 367) Cefdinir was independently associated with treatment failure with nearly twice as high of failure rate compared with cephalexin for the treatment of outpatient uncomplicated UTI #IDXposts #UTIWiki
academic.oup.com
Due to its poor bioavailability and urinary excretion, cefdinir may be a suboptimal agent for UTI treatment. Our findings demonstrate that patients treated
4
13
48
‼️Just shared at #IDWeek2025, our findings are now published in @OFIDJournal comparing cephalexin to cefdinir for uUTI in females. Spoiler: cefdinir was the only independent risk factor associated with/failure. Poor urinary PK = ⬆️failure. Let’s stop Rx’ing cefdinir for UTI! 🛑💊
0
27
89
👋 I have a few copies of the drug name emoji game deck of cards for only $20. Find me at #IDweek2025
0
2
9
Today is the day! Join us for the @SIDPharm Poster Walk, led by SIDP Paper of the Year award winners, Ryan Shields & Jason Pogue! Meet us at the SIDP booth at 12:30 to join the fun & learn from our experts! #IDWeek2025 #SIDP2025
1
0
5
At #IDWeek2025? Be sure to stop by the @SIDPharm Booth for more amazing swag, photo ops, & our poster walk today! #SIDP2025
0
0
3
Step into the shoes of the stewardship team for “A Day with the Antimicrobial Stewardship Pager,” presented by @LisaIDpharmD, @RebeccaSame, Christine Lockowitz, PharmD, BCIDP, @DrKevinSchwartz, @EStohs, and @NPT_PharmD.
1
4
9
New episode alert! ‼️ Breakpoints first multi-language episode! Check out episode #122, focused on antimicrobial stewardship in Latin America. So grateful for all team members who worked diligently to bring this project to life! #NewEpisode #Breakpoints
1
0
3
‼️Excited to share our work (just in time for URI season!) implementing order sentences for URI supportive care as an effective way to reduce outpatient abx prescribing. Shout out to our incredible AmbCare team partnering to implement this intervention!
cambridge.org
Impact of a multifaceted intervention including supportive care order sentence implementation on outpatient antibiotic prescribing for upper respiratory tract infections - Volume 5 Issue 1
0
2
17
Not posting much on here these days, but had to give a shout out to former student & current HFH PGY2 ID resident @Cole_Orlikowski on his 1st publication! Check out our thoughts on risk factors to consider when implementing lipoglycopeptides in the ED! https://t.co/jw6zWIAQLC
journals.sagepub.com
Background: Cellulitis is a common cause of hospitalization imposing significant burden on healthcare systems. Treatment disposition is dependent on extent and ...
0
1
15
Excited to share this work published in @ASHE_Journal completed by our recent pharmacy resident graduates, Mackenzie Miller & @NoahBID! We have a lot of work to do in the outpatient setting to improve prescribing for SSTIs 💊 #outpatientstewie
@LisaIDpharmD; @NoahBID; @DrJaymoGR: Outpatient prescribing for purulent cellulitis in obesity was highly variable across a MI health system. Nearly 1/2 were underdosed. Extended durations did not impact treatment success.
1
1
16
🚨 New @SIDPharm #Breakpoints Episode! 🎙️ Join Drs. @Cortes_Penfield, @JessieLSeidel, @Kerry_LaPlante, & me to discuss biofilms in PJIs. 🧫, what the lab tells us about the best drugs 💊, & the innovative non-pharmacological strategies (more than just 🦴 cement!). #IDTwitter
1
9
30
📢 ‼️ Have you ever wanted to host Breakpoints? Now is your chance! Looking for engaging @SIDPharm members to audition to host everyone’s favorite podcast. Details can be found at: https://t.co/H6QHxwV9Xt
0
2
7
Promotion, publication, award, or innovative practice? SIDP would like to highlight your achievements in the upcoming newsletter! Please take 2 minutes to highlight your work in this form: https://t.co/M2w1nyBGSZ. Bookmark it to submit your accomplishments year round.
0
2
2
Claim your CME/CPE/CNE/MOC credits for #IDWeek2024! Log in to check the individual session listing in the IDWeek Interactive Program for more details. https://t.co/UCpieI4PLz
0
2
6